title: Ultra-long-acting insulins for a lifestyle-related pandemic.
authors.affiliation: Endocrinology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. Kudva.yogish@mayo.edu
authors.forename: Yogish C
authors.initials: YC
authors.lastname: Kudva
authors.forename: Ananda
authors.initials: A
authors.lastname: Basu
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting / Q000008:administration & dosage*
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting